Panel: Addressing Common & Diverse Challenges in Adopting & Implementing Spatial Technologies Across Drug Development
Time: 8:00 am
day: Conference Day 1
Details:
- Understanding how industry experts select the right spatial biology tool for their study, be it based on disease indication, modality, stage within the pharma value chain or other criteria
- Soundboarding ideas to overcome barriers to internal entry including cost, time and hesitancy to adopt new technology
- Uncovering approaches when it comes to analyzing the data infrastructure and what needs to be built in-house to support the integration of new spatial biology technologies
Moderated by Deidre Dalmas, Director – Global Investigative Safety, Nonclinical Safety Project Lead, Formerly GSK